Subscribe to Newsletter

Dalvir Gill

The Power List 2017 – Champions of Change

Dalvir Gill

Chief Executive Officer and Member of the Board of Directors, TransCelerate BioPharma

Dalvir Gill was appointed as CEO of TransCelerate in January 2013 and has since pioneered a number of changes and improvements to the drug development process. He has also been involved in launching BioCelerate, a subsidiary of TransCelerate, and its first initiative in Toxicology Data Sharing.

Part of the Power List 2017

Our Top 100 into 4 categories

Go to The Power List 2017

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine